EyePoint Pharmaceuticals ... (EYPT)
NASDAQ: EYPT
· Real-Time Price · USD
11.32
0.23 (2.07%)
At close: Aug 18, 2025, 3:59 PM
11.33
0.09%
After-hours: Aug 18, 2025, 04:10 PM EDT
EyePoint Pharmaceuticals Revenue
EyePoint Pharmaceuticals reported an annual revenue of $43.27M, reflecting a -5.97% growth. For the quarter ending June 30, 2025, EyePoint Pharmaceuticals generated $5.33M in revenue.
Revenue (ttm)
43.27M
Revenue Growth
-5.97%
Price / Sales Ratio
9.69
Revenue / Employee
262.26K
Employees
165
Market Cap
780.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 43.27M | -5.97% |
Dec 31, 2023 | 46.02M | +11.14% |
Dec 31, 2022 | 41.4M | +12.09% |
Dec 31, 2021 | 36.94M | +7.27% |
Dec 31, 2020 | 34.44M | +69.10% |
Dec 31, 2019 | 20.36M | +587.77% |
Jun 30, 2018 | 2.96M | -60.72% |
Jun 30, 2017 | 7.54M | +365.37% |
Jun 30, 2016 | 1.62M | -93.90% |
Jun 30, 2015 | 26.57M | +664.90% |
Jun 30, 2014 | 3.47M | +62.06% |
Jun 30, 2013 | 2.14M | -39.22% |
Jun 30, 2012 | 3.53M | -28.98% |
Jun 30, 2011 | 4.96M | -78.46% |
Jun 30, 2010 | 23.05M | +89.55% |
Jun 30, 2009 | 12.16M | +249.88% |
Jun 30, 2008 | 3.48M | +55.53% |
Jun 30, 2007 | 2.23M | +52.52% |
Jun 30, 2006 | 1.47M | +132.78% |
Jun 30, 2005 | 629.52K | +137.35% |
Jun 30, 2004 | 265.23K | +256.73% |
Jun 30, 2003 | 74.35K | -85.60% |
Jun 30, 2002 | 516.32K | n/a |